Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-14

“Impressive” and “Outstanding” are not terms thrown around without due evidence.

Congratulations to the brave patients who made this result possible - and thoughts to the families of those who were simply too far gone to benefit. Their sacrifice will save many lives in time.

I know many of us are exhausted from years of dreadful, disconnected market conditions. I hope this release is a reminder of how rare and powerful - and safe - this molecule is.

In time, bisantrene will return to the market and you can all say you were a small part of that.